Letters Universal meningitis vaccination

Winter is coming: vaccine negotiations should be concluded swiftly

BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g6748 (Published 13 November 2014) Cite this as: BMJ 2014;349:g6748
  1. Linda Glennie, head of research and medical information1,
  2. Claire Wright, medical information officer1,
  3. Christopher Head, chief executive officer1
  1. 1Meningitis Research Foundation, Bristol BS35 2BS, UK
  1. lindag{at}meningitis.org

The Meningitis Research Foundation welcomes publication of Christensen and colleagues’ model,1 which enables comparison with their original study2 and the interim opinion of the Joint Committee on Vaccination and Immunisation (JCVI),3 and shows a range of cost effective options.

However, this model undervalues the impact of meningococcal B infection. As we previously argued,4 the MOSAIC study,5 which underlies many parameters in this model, is a snapshot that inevitably underestimates disease burden.

In addition, …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe